Jump to content
RemedySpot.com

Time for patient action? to advocate for effective biospecimen based research - for caHUB

Rate this topic


Recommended Posts

Guest guest
Posted

Greetings,

How many of us can recall reading the consent document regarding the use of

extra biopsy tissue? . And if we did, how could we be expected to understand

its implications, or our other choices?

Only recently considered something to discard, the evaluation of biospecimen

- particularly when annotated with clinical information (response to

therapy, etc.) -- is considered the key to making progress against

lymphomas, a heterogeneous condition which has variable clinical courses and

underlying biologies.

Presently, pathology departments, the institution, the investigators, the

cooperative groups, even NCI, argue for use of it . the patient community

unaware that it has become so valuable, and that " ownership " of it has

become so problematic!

Importantly, with the recent advent of caHUB*, we now have an alternative to

a fragmented and contentious system: Instead of tissue being used to its

best advantage, it remains unused because of ownership battles . or the use

of it defaults to individual researchers in the center who have access to

the refrigerator - a poor substitute for what's possible today. Done in

isolation on relatively small numbers of sample, this use of patient tissue

is unlikely to achieve anything of clinical importance.

* What is caHUB? It's a " national biobank, or biorespository, of human

tissue, blood, and other biological materials--collectively known as

biospecimens--that can be used for medical research. It will help ensure

that an adequate and continuous supply of biospecimens is available to

accelerate cancer research and the development of molecularly-based

diagnostic and therapeutic agents that will further enable personalized

medicine. " See for more: http://bit.ly/doVai4

So I think patients need legal counsel regarding the use of biopsy tissue

for research . and government regulation to standardize consent and

ownership practices -- to protect the interests of patients and to save

well-meaning, human, all-to-human, researchers from themselves.

The carrot: Institutions that participate in caHUB, should be awarded

generous grants and public acknowledgments.

The stick: institutions who do not offer this option to patients, must

discard the extra tissue unless they can show its use has a true potential

to advance clinical science, and the institutions have provided patients

with adequate consenting and knowledge of the alternative.

The reason patient intervention (through legislation) is needed is to make

possible an individualized approach to a heterogeneous disease . which

requires cooperative studies based on biospecimen that is uniformly analyzed

- what caHUB offers, and apparently what most researchers will not accept in

practice, even when they agree with the concept.

To illustrate, I copy comment of an unnamed investigator on the competition

for use of biospecimen:

" Doctors who work in the field disagree many individual sites disagree with

the NCI - e.g. many good centers don't participate in cooperative group

studies because they disagree, don't like, or have other priorities. Our XYZ

lymphoma committee often disagrees with the NCI CTEP staff - so for us to

send samples from our patients to the NCI to be used on studies we don't

favor is problematic if we disagree - we will not be motivated to

participate - very very challenging. . When patients have a biopsy, the

operative consent form generally mentions " waste tissue " - this falls into

that category. As I understand it, the patient has no clear rights to

" waste tissue " , which would generally not be needed for diagnostic purposes

and is therefore discarded. The generic consent form says that this may be

used by the institution for research or other purposes (as it is otherwise

waste) in a de-identified way. "

What is step one? First, we need feedback from the NCI and research

community to make sure our concerns are legitimate and the proposed remedy

is feasible.

~ Karl

Patients Against Lymphoma

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...